Synergism of PARP inhibitor and MET inhibitor in multiple cancer types with intrinsic and acquired PARP inhibitor resistances

被引：1

作者：

Chen, Mei-Kuang ^{[1
]}

Xia, Weiya ^{[1
]}

Dong, Qiongzhu ^{[2
]}

Du, Yi ^{[3
]}

Wang, Hung-Ling ^{[4
]}

Tapia, Coya ^{[1
]}

Wei, Yongkun ^{[1
]}

Han, Ye ^{[5
]}

Chu, Yu-Yi ^{[1
]}

Yam, Clinton ^{[1
]}

Gao, Yuan ^{[1
]}

Wang, Yu-Han ^{[1
]}

Meric-Bernstam, Funda ^{[1
]}

Liu, Jinsong ^{[1
]}

Wang, Shao-Chun ^{[4
]}

Yu, Dihua ^{[1
]}

Hung, Mien-Chie ^{[4
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Fudan Univ, Shanghai, Peoples R China

[3] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA

[4] China Med Univ, Taichung, Taiwan

[5] China Med Univ, Affiliated Shengjing Hosp, Shenyang, Peoples R China

来源：

关键词：

D O I：

10.1158/1538-7445.AM2020-5682

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5682

引用

页数：2

共 50 条

[21] PARP Inhibitor Activates the Intrinsic Pathway of Apoptosis in Primary Lung Cancer Cells
Gangopadhyay, Nupur N.
Luketich, James D.
Opest, Amy
Landreneau, Rodney
Schuchert, Matthew J.
[J]. CANCER INVESTIGATION, 2014, 32 (07) : 339 - 348
[22] Mechanisms of PARP inhibitor resistance in ovarian cancer
Kubalanza, Kari
Konecny, Gottfried E.
[J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2020, 32 (01) : 36 - 41
[23] PARP inhibitor combination therapy
Drean, Amy
Lord, Christopher J.
Ashworth, Alan
[J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 108 : 73 - 85
[24] Tackling PARP inhibitor resistance
Fugger, Kasper
Hewitt, Graeme
West, Stephen C.
Boulton, Simon J.
[J]. TRENDS IN CANCER, 2021, 7 (12): : 1102 - 1118
[25] Biomarkers of PARP inhibitor sensitivity
Nicholas C. Turner
Alan Ashworth
[J]. Breast Cancer Research and Treatment, 2011, 127 : 283 - 286
[26] Imaging Pharmacodynamics of a PARP Inhibitor
Luker, Gary D.
[J]. RADIOLOGY-IMAGING CANCER, 2021, 3 (03):
[27] Talazoparib (Talzenna®), a PARP inhibitor
Buxeraud, Jacques
Faure, Sebastien
[J]. ACTUALITES PHARMACEUTIQUES, 2022, 61 (614): : 11 - 12
[28] Efficacy of a PARP inhibitor combination
Bradley C.A.
[J]. Nature Reviews Urology, 2018, 15 (9) : 526 - 526
[29] Takeda licenses PARP inhibitor
Jarvis, Lisa
[J]. CHEMICAL & ENGINEERING NEWS, 2017, 95 (32) : 13 - 13
[30] Biomarkers of PARP inhibitor sensitivity
Turner, Nicholas C.
Ashworth, Alan
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 283 - 286